Travere Thereapeutics News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

26.10.24	Travere Therapeutics Highlights Clinical Benefits Of FILSPARI For IgA Nephropathy And FSGS (RTTNews)
17.10.24	Travere Therapeutics Secures Swiss Authorization For FILSPARI To Treat IgA Nephropathy (RTTNews)
09.10.24	Belite Delights Investors, Soleno, ADMA, Harrow Deliver Triple-digit Gains, Keep An Eye On Oculis (RTTNews)
27.09.24	Travere Therapeutics Pauses Enrollment In Phase 3 Study Of Pegtibatinase For Manufacturing Scale-Up (RTTNews)
21.09.24	FDA Approval Propels ZVRA To 52-week High, ADMA, CPRX, TVTX Also Reach New Peaks (RTTNews)
20.09.24	EWTX Yields Over 300% Returns, ADMA Records 200% Gains - Did You Strike While The Iron Is Hot? (RTTNews)
02.09.24	Biotech Stocks Facing FDA Decision In September 2024 (RTTNews)
24.04.24	Travere Therapeutics Says European Commission Approved Filspari To Treat IgA Nephropathy (RTTNews)
11.03.24	Travere Therapeutics Submits SNDA Seeking Full Approval Of Filspari In IgA Nephropathy (RTTNews)
23.02.24	CSL Vifor : Sparsentan Receives Positive CHMP Opinion For Treatment Of IgA Nephropathy (RTTNews)
18.02.23	FDA Grants Accelerated Approval To Travere's Filspari For IgA Nephropathy Treatment (RTTNews)
29.01.23	Biotech Stocks Facing FDA Decision In February 2023 (RTTNews)
28.10.22	ALNY Reiterates Guidance, TVTX Loss Widens, DXCM Paints Rosy Outlook (RTTNews)
16.09.21	Vifor Pharma, Travere Reach Deal For Commercialization Of Kidney Disease Medicine Sparsentan (RTTNews)
26.05.21	LRMR Hit By 'double Whammy', PRVB On Watch, TLC Comes To India's Rescue To Fight Black Fungus (RTTNews)
03.02.21	SAVA Jumps From $7 To $75 In Just 3 Weeks, DRRX Gets FDA Nod, IMVT Pauses Trials, OCGN Catches Eye (RTTNews)
02.02.21	Stock Alert: Travere Therapeutics Hits New High; Positive News On Drug Candidate Sparsentan (RTTNews)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	309.10	2.90 %	K V
Holcim	90.66	2.49 %	K V
Part Grp Hldg	1’227.00	1.49 %	K V
Lonza Grp	521.20	1.48 %	K V
Swiss Life Hldg	726.60	1.37 %	K V
Alcon	75.88	0.37 %	K V
Nestle	76.92	0.34 %	K V
Novartis	91.29	0.25 %	K V
Givaudan	3’876.00	0.16 %	K V
Kuehne+Nagel Int	210.50	0.05 %	K V